Oaktree Specialty Lending Corporation filed a Form 8-K on September 16, 2026, disclosing the closing of a $300.0 million offering of 7.000% Notes due 2031 and the execution of a Ninth Supplemental Indenture with Deutsche Bank Trust Company Americas as trustee.
Key Highlights
- Offering size: $300.0 million aggregate principal amount of 7.000% Notes due 2031 were issued on September 16, 2026.
- Maturity date: The Notes mature on September 16, 2031, unless previously redeemed or repurchased.
- Interest payments: The Notes bear interest at 7.000% per year, payable semiannually on March 16 and September 16, commencing March 16, 2027.
- Use of proceeds: The company disclosed it expects to use net proceeds to reduce outstanding debt under its senior secured revolving credit facility and for general corporate purposes, including potentially repaying its 2.700% notes due 2027 at maturity.
- Redemption feature: Prior to August 16, 2031 (the Par Call Date), the company may redeem the Notes at the greater of a make-whole amount or 100% of principal; on or after the Par Call Date, at 100% of principal plus accrued interest.
- Change of control: If a Change of Control Repurchase Event occurs prior to maturity, holders may require the company to repurchase Notes at 100% of principal plus accrued and unpaid interest.
Oaktree Specialty Lending Closes $300M Unsecured Notes Offering, Executes Ninth Supplemental Indenture
According to the filing, Oaktree Specialty Lending Corporation (NASDAQ:OCSL) and Deutsche Bank Trust Company Americas entered into the Ninth Supplemental Indenture on September 16, 2026, supplementing the original Indenture dated April 30, 2012. The Ninth Supplemental Indenture governs the issuance of $300.0 million in aggregate principal amount of 7.000% Notes due 2031, and the transaction closed on September 16, 2026.
The filing describes the Notes as "the Company's direct, unsecured obligations" that rank senior in right of payment to expressly subordinated future indebtedness, equal to existing and future unsecured indebtedness that is not subordinated, effectively junior to any secured indebtedness to the extent of the value of the assets securing such indebtedness, and structurally junior to all indebtedness incurred by the company's subsidiaries, financing vehicles, or similar facilities. The Notes were offered pursuant to the company's effective shelf registration statement on Form N-2 (Registration No. 333-292920), with a final prospectus supplement dated September 9, 2026.
The Indenture as supplemented contains covenants, including a requirement for the company to comply with Section 18(a)(1)(A) as modified by Section 61(a)(1) and (2) of the Investment Company Act of 1940, as amended, subject to any exemptive relief granted by the SEC, and to provide financial information to holders and the Trustee if the company is no longer subject to Exchange Act reporting requirements. The Notes will not be subject to any sinking fund, according to the filing. The filing was signed by Christopher McKown, Chief Financial Officer and Treasurer.
What Was Disclosed
Oaktree Specialty Lending Corporation disclosed the closing of a $300.0 million unsecured notes offering at a 7.000% annual rate maturing September 16, 2031, the execution of the Ninth Supplemental Indenture, and the intended use of net proceeds to reduce revolving credit facility borrowings and for general corporate purposes.




Please wait processing your request...